Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and eravacycline

carbapenems has been researched along with eravacycline in 15 studies

Compound Research Comparison

Studies
(carbapenems)		Trials
(carbapenems)		Recent Studies (post-2010)
(carbapenems)		Studies
(eravacycline)		Trials
(eravacycline)		Recent Studies (post-2010) (eravacycline)
7,3551475,27795393

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)eravacycline (IC50)
30S ribosomal protein S6Escherichia coli K-120.62
30S ribosomal protein S7Escherichia coli K-120.62
50S ribosomal protein L15Escherichia coli K-120.62
50S ribosomal protein L10Escherichia coli K-120.62
50S ribosomal protein L11Escherichia coli K-120.62
50S ribosomal protein L7/L12Escherichia coli K-120.62
50S ribosomal protein L19Escherichia coli K-120.62
50S ribosomal protein L1Escherichia coli K-120.62
50S ribosomal protein L20Escherichia coli K-120.62
50S ribosomal protein L27Escherichia coli K-120.62
50S ribosomal protein L28Escherichia coli K-120.62
50S ribosomal protein L29Escherichia coli K-120.62
50S ribosomal protein L31Escherichia coli K-120.62
50S ribosomal protein L31 type BEscherichia coli K-120.62
50S ribosomal protein L32Escherichia coli K-120.62
50S ribosomal protein L33Escherichia coli K-120.62
50S ribosomal protein L34Escherichia coli K-120.62
50S ribosomal protein L35Escherichia coli K-120.62
50S ribosomal protein L36Escherichia coli K-120.62
30S ribosomal protein S10Escherichia coli K-120.62
30S ribosomal protein S11Escherichia coli K-120.62
30S ribosomal protein S12Escherichia coli K-120.62
30S ribosomal protein S13Escherichia coli K-120.62
30S ribosomal protein S16Escherichia coli K-120.62
30S ribosomal protein S18Escherichia coli K-120.62
30S ribosomal protein S19Escherichia coli K-120.62
30S ribosomal protein S20Escherichia coli K-120.62
30S ribosomal protein S2Escherichia coli K-120.62
30S ribosomal protein S3Escherichia coli K-120.62
30S ribosomal protein S4Escherichia coli K-120.62
30S ribosomal protein S5Escherichia coli K-120.62
30S ribosomal protein S8Escherichia coli K-120.62
30S ribosomal protein S9Escherichia coli K-120.62
50S ribosomal protein L13Escherichia coli K-120.62
50S ribosomal protein L14Escherichia coli K-120.62
50S ribosomal protein L16Escherichia coli K-120.62
50S ribosomal protein L23Escherichia coli K-120.62
30S ribosomal protein S15Escherichia coli K-120.62
50S ribosomal protein L17Escherichia coli K-120.62
50S ribosomal protein L21Escherichia coli K-120.62
50S ribosomal protein L30Escherichia coli K-120.62
50S ribosomal protein L6Escherichia coli K-120.62
30S ribosomal protein S14Escherichia coli K-120.62
30S ribosomal protein S17Escherichia coli K-120.62
30S ribosomal protein S1Escherichia coli K-120.62
50S ribosomal protein L18Escherichia coli K-120.62
50S ribosomal protein L2Escherichia coli K-120.62
50S ribosomal protein L3Escherichia coli K-120.62
50S ribosomal protein L24Escherichia coli K-120.62
50S ribosomal protein L4Escherichia coli K-120.62
50S ribosomal protein L22Escherichia coli K-120.62
50S ribosomal protein L5Escherichia coli K-120.62
30S ribosomal protein S21Escherichia coli K-120.62
50S ribosomal protein L25Escherichia coli K-120.62
50S ribosomal protein L36 2Escherichia coli K-120.62

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (26.67)24.3611
2020's11 (73.33)2.80

Authors

AuthorsStudies
Livermore, DM; Mushtaq, S; Warner, M; Woodford, N1
Bush, K; Lin, X; Zhang, Y1
Cuhadar, T; Demirbas Gulmez, Z; Dizbay, M; Guzel Tunccan, O; Kalkanci, A; Ozger, HS; Simsek, H; Unaldi, O; Yildiz, SS1
Izmailyan, S; Lawrence, K; Olesky, M; Solomkin, JS; Sway, A; Tsai, L1
Chiotos, K; Gerber, JS; Hayes, M; Tamma, PD1
Anacker, M; Castanheira, M; Johnson, JR; Johnston, BD; Porter, SB; Snippes Vagnone, P; Thuras, P; VonBank, B; Witwer, M1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A1
Chatzidimitriou, D; Chatzidimitriou, M; Chatzivasileiou, P; Chatzopoulou, F; Katsifa, E; Kavvada, A; Kyriazidi, M; Mavridou, M; Meletis, G; Mitka, S; Rousis, D; Sakellariou, G; Theodoros, L; Vagdatli, E1
Almangour, TA; Bassetti, M; Eljaaly, K; Ortwine, JK; Shaikhomer, M1
Cui, L; Li, Y; Wang, Q; Xue, F; Zheng, B1
Başustaoğlu, A; Güçlü, AÜ; İnce Ceviz, G; Mirza, HC1
Chen, TY; Hsu, CK; Lai, CC; Shih, SC; Tang, HJ; Weng, TS1
Chen, J; Jia, W; Jing, R; Li, J; Liu, Y; Sun, G; Sun, H; Wang, T; Xu, X; Xu, Y; Zhang, G1
Damodaran, N; Leela, KV; Maheswary, D; Rahul, R1

Reviews

5 review(s) available for carbapenems and eravacycline

ArticleYear
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.
    Journal of the Pediatric Infectious Diseases Society, 2020, Feb-28, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Polymyxins; Sisomicin; Tetracyclines; Tigecycline

2020
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
A plethora of carbapenem resistance in
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines

2021
Efficacy and safety of eravacycline: A meta-analysis.
    Journal of global antimicrobial resistance, 2021, Volume: 24

    Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intraabdominal Infections; Tetracyclines

2021
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Humans; Intraabdominal Infections; Randomized Controlled Trials as Topic; Tazobactam

2023

Trials

1 trial(s) available for carbapenems and eravacycline

ArticleYear
Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance.
    Future microbiology, 2019, Volume: 14

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Data Interpretation, Statistical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Female; Humans; Intraabdominal Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracyclines; Young Adult

2019

Other Studies

9 other study(ies) available for carbapenems and eravacycline

ArticleYear
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tetracyclines; Tigecycline

2016
In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.
    The Journal of antibiotics, 2016, Volume: 69, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tetracyclines

2016
In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates.
    The Journal of antibiotics, 2019, Volume: 72, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Tetracyclines

2019
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
    Antimicrobial agents and chemotherapy, 2020, 09-21, Volume: 64, Issue:10

    Topics: Anti-Bacterial Agents; Asia; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Europe; Latin America; Microbial Sensitivity Tests; Phylogeny; Tetracyclines; United States

2020
Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals.
    Acta microbiologica et immunologica Hungarica, 2021, Jun-21, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Greece; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tetracyclines

2021
Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii.
    Journal of global antimicrobial resistance, 2022, Volume: 30

    Topics: Acinetobacter baumannii; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Polymyxin B; Tetracyclines

2022
Comparative
    Journal of medical microbiology, 2022, Volume: 71, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tetracyclines; Tigecycline

2022
    Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefepime; Microbial Sensitivity Tests; Tigecycline

2023
Eravacycline -Synergistic activity with other antimicrobials in carbapenem resistant isolates of Escherichia coli and Acinetobacter baumannii.
    Diagnostic microbiology and infectious disease, 2023, Volume: 107, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Polymyxin B

2023